Pricing Log in Create free account

Aclaris Therapeutics, Inc. (ACRS) vs Bicara Therapeutics Inc. (BCAX)

Aclaris Therapeutics, Inc. and Bicara Therapeutics Inc. are both Biotechnology companies. Aclaris Therapeutics, Inc. and Bicara Therapeutics Inc. are of similar size ($559.5M and $542.0M). Bicara Therapeutics Inc. has the higher net margin (0.00% vs −1,244.1%) and the higher return on invested capital (0.00% vs −107.7%). Across the 12 metrics below, Bicara Therapeutics Inc. leads on 8 and Aclaris Therapeutics, Inc. on 4.

Valuation

Metric ACRS BCAX Biotechnology median
P/E n/m n/m 10.60
P/S 90.59 n/m 9.40
P/B 3.48 1.25 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 74.41 n/m 9.02
Earnings yield (14.95%) (36.00%) (32.88%)
Free cash flow yield (12.99%) (23.13%) (23.13%)

Profitability

Metric ACRS BCAX Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin (1,413.97%) 0.00% 0.00%
Net margin (1,244.09%) 0.00% 0.00%
Free cash flow margin (1,176.61%) 0.00% 0.00%
Return on equity (55.51%) (41.01%) (51.96%)
Return on assets (40.66%) (38.38%) (46.06%)
Return on invested capital (107.72%) 0.00% 0.00%

Growth

Metric ACRS BCAX Biotechnology median
Revenue growth (TTM) (59.34%) — 6.76%
EPS growth (last fiscal year) 69.01% 37.78% 29.88%
Revenue growth, 5-year CAGR 3.84% — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ACRS BCAX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.09 11.59 4.97
Net debt to EBITDA 1.20 2.67 1.01

Dividend

Metric ACRS BCAX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ACRS BCAX Biotechnology median
Market cap 559.49m 541.96m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack